FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

78447009: Phospholipid (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
130173017 Phospholipid en Synonym Active Entire term case insensitive SNOMED CT core module
819388010 Phospholipid (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
113321601000001112 Phospholipids en Synonym Active Entire term case insensitive SNOMED CT United Kingdom Edition module

47 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Phospholipid Is a Lipid true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Sphingomyelin Is a True Phospholipid Inferred relationship Existential restriction modifier
Phosphoglyceride Is a True Phospholipid Inferred relationship Existential restriction modifier
Lipids, phospholipids measurement Has measured component False Phospholipid Inferred relationship Existential restriction modifier
Phospholipid measurement Has measured component False Phospholipid Inferred relationship Existential restriction modifier
Lipids, phospholipids measurement Component False Phospholipid Inferred relationship Existential restriction modifier
Phospholipid measurement Component True Phospholipid Inferred relationship Existential restriction modifier 1
Phospholipid + protein 35mg/0.65mg suspension Has active ingredient False Phospholipid Inferred relationship Existential restriction modifier
Sodium glycerophosphate Is a False Phospholipid Inferred relationship Existential restriction modifier
Liposomal agent Is a True Phospholipid Inferred relationship Existential restriction modifier
Egg phospholipid Is a True Phospholipid Inferred relationship Existential restriction modifier
Egg phosphatide Is a True Phospholipid Inferred relationship Existential restriction modifier
Miltefosine Is a True Phospholipid Inferred relationship Existential restriction modifier
Glycerophosphocholine Is a True Phospholipid Inferred relationship Existential restriction modifier
Phosphatidylethanol Is a True Phospholipid Inferred relationship Existential restriction modifier
Product containing phospholipid Has active ingredient True Phospholipid Inferred relationship Existential restriction modifier 1
Beractant Is a True Phospholipid Inferred relationship Existential restriction modifier
Product containing precisely phospholipid (as beractant) 200 milligram/8 milliliter conventional release suspension for endotracheopulmonary instillation bottle Has basis of strength substance False Phospholipid Inferred relationship Existential restriction modifier 1
Product containing precisely phospholipid (as poractant alfa) 240 milligram/3 milliliter conventional release suspension for endotracheopulmonary instillation vial Has basis of strength substance False Phospholipid Inferred relationship Existential restriction modifier 1
Product containing precisely phospholipid (as poractant alfa) 120 milligram/1.5 milliliter conventional release suspension for endotracheopulmonary instillation vial Has basis of strength substance False Phospholipid Inferred relationship Existential restriction modifier 1
Product containing precisely phospholipid (as beractant) 25 milligram/1 milliliter conventional release suspension for endotracheopulmonary instillation (clinical drug) Has basis of strength substance True Phospholipid Inferred relationship Existential restriction modifier 1
Allergy to phospholipid Causative agent True Phospholipid Inferred relationship Existential restriction modifier 1
Cholesterol/phospholipid ratio measurement Component True Phospholipid Inferred relationship Existential restriction modifier 4
Cholesterol/phospholipid ratio measurement Component False Phospholipid Inferred relationship Existential restriction modifier
Substance concentration ratio of phospholipid to cholesterol in serum (observable entity) Component True Phospholipid Inferred relationship Existential restriction modifier 1
Poractant alfa 240mg/3mL sterile suspension Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Phospholipid Inferred relationship Existential restriction modifier
Curosurf 240mg/3ml endotracheopulmonary suspension vials (Trinity Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Phospholipid Inferred relationship Existential restriction modifier
Curosurf 240mg/3ml endotracheopulmonary suspension vials (Trinity Pharmaceuticals Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Phospholipid Inferred relationship Existential restriction modifier
Poractant alfa 240mg/3ml endotracheopulmonary suspension vials 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Phospholipid Inferred relationship Existential restriction modifier
Poractant alfa 120mg/1.5mL sterile suspension Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Phospholipid Inferred relationship Existential restriction modifier
Curosurf 120mg/1.5ml endotracheopulmonary suspension vials (Trinity Pharmaceuticals Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Phospholipid Inferred relationship Existential restriction modifier
Curosurf 120mg/1.5ml endotracheopulmonary suspension vials (Trinity Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Phospholipid Inferred relationship Existential restriction modifier
Poractant alfa 120mg/1.5ml endotracheopulmonary suspension vials 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Phospholipid Inferred relationship Existential restriction modifier
Beractant 200mg/8mL suspension Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Phospholipid Inferred relationship Existential restriction modifier
Survanta 200mg/8ml endotracheopulmonary suspension bottles (Abbott Laboratories Ltd) 1 bottle Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Phospholipid Inferred relationship Existential restriction modifier
Survanta 200mg/8ml endotracheopulmonary suspension bottles (Abbott Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Phospholipid Inferred relationship Existential restriction modifier
Beractant 200mg/8ml endotracheopulmonary suspension bottles 1 bottle Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Phospholipid Inferred relationship Existential restriction modifier
Poractant alfa 240mg/3mL sterile suspension Has basis of strength substance False Phospholipid Inferred relationship Existential restriction modifier
Curosurf 240mg/3ml endotracheopulmonary suspension vials (Trinity Pharmaceuticals Ltd) Has basis of strength substance True Phospholipid Inferred relationship Existential restriction modifier
Curosurf 240mg/3ml endotracheopulmonary suspension vials (Trinity Pharmaceuticals Ltd) 1 vial Has basis of strength substance True Phospholipid Inferred relationship Existential restriction modifier
Poractant alfa 240mg/3ml endotracheopulmonary suspension vials 1 vial Has basis of strength substance True Phospholipid Inferred relationship Existential restriction modifier
Poractant alfa 120mg/1.5mL sterile suspension Has basis of strength substance False Phospholipid Inferred relationship Existential restriction modifier
Curosurf 120mg/1.5ml endotracheopulmonary suspension vials (Trinity Pharmaceuticals Ltd) 1 vial Has basis of strength substance True Phospholipid Inferred relationship Existential restriction modifier
Curosurf 120mg/1.5ml endotracheopulmonary suspension vials (Trinity Pharmaceuticals Ltd) Has basis of strength substance True Phospholipid Inferred relationship Existential restriction modifier
Poractant alfa 120mg/1.5ml endotracheopulmonary suspension vials 1 vial Has basis of strength substance True Phospholipid Inferred relationship Existential restriction modifier
Beractant 200mg/8mL suspension Has basis of strength substance False Phospholipid Inferred relationship Existential restriction modifier
Survanta 200mg/8ml endotracheopulmonary suspension bottles (Abbott Laboratories Ltd) 1 bottle Has basis of strength substance True Phospholipid Inferred relationship Existential restriction modifier
Survanta 200mg/8ml endotracheopulmonary suspension bottles (Abbott Laboratories Ltd) Has basis of strength substance True Phospholipid Inferred relationship Existential restriction modifier
Beractant 200mg/8ml endotracheopulmonary suspension bottles 1 bottle Has basis of strength substance True Phospholipid Inferred relationship Existential restriction modifier
Beractant 200mg/8ml endotracheopulmonary suspension bottles Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Phospholipid Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start